Children's Oncology Group's 2023 blueprint for research: Radiation oncology

John A. Kalapurakal*, Suzanne L. Wolden, Daphne Haas-Kogan, Nadia N. Laack, Chia ho Hua, Arnold C. Paulino, Christine E. Hill-Kayser, Bradford S. Hoppe, Thomas J. Fitzgerald

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.

Original languageEnglish (US)
Article numbere30593
JournalPediatric Blood and Cancer
Volume70
Issue numberS6
DOIs
StatePublished - Sep 2023

Keywords

  • chemotherapy
  • late effects of cancer treatment
  • long-term survival
  • molecular biology
  • radiation therapy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Children's Oncology Group's 2023 blueprint for research: Radiation oncology'. Together they form a unique fingerprint.

Cite this